Cancer is complex and dynamic Ergo, dose optimization calls for mathematical modeling Written by Sandy Anderson, Robert Gillies, Robert Gatenby on May 18, 2022
Rethinking Angiogenesis Behind the paper Written by Youness Azimzade, Robert Gatenby on April 05, 2021
Mathematical Modeling in Cancer Therapy - The Importance of After-Action Analysis "Cancer therapy outcomes are increasingly limited by the evolution of resistance rather than lack of effective drugs. Integrating principles from..." Presented by Robert Gatenby, at MathOnco25 on October 30, 2025